TXMD

1.29

7.86% -0.11

Dopo l'orario di chiusura: 1.28 -0.01 -0.78%

Therapeuticsmd Inc (TXMD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.40

Aprire:

$1.4

Volume 24 ore:

84,810

Relative Volume:

5.40

Capitalizzazione di mercato:

$16.01M

Reddito:

$996.00K

Utile/perdita netta:

$-6.09M

Rapporto P/E:

0.2873

EPS:

4.49

Flusso di cassa netto:

$-9.76M

1 W Prestazione:

-15.13%

1M Prestazione:

-19.38%

6M Prestazione:

-41.89%

1 anno Prestazione:

-43.17%

Intervallo 1D:

$1.15

$1.45

Intervallo di 1 settimana:

$1.15

$1.55

Portata 52W:

$1.15

$3.07

Therapeuticsmd Inc Stock (TXMD) Company Profile

Nome

Therapeuticsmd Inc

Settore

Healthcare (1196)

Industria

Drug Manufacturers - Specialty & Generic (87)

Telefono

561-961-1900

Indirizzo

951 YAMATO ROAD, SUITE 220, BOCA RATON, FL

Dipendente

Cinguettio

@TherapeuticsMD

Prossima data di guadagno

2024-11-12

Ultimi documenti SEC

TXMD's Discussions on Twitter

Confronta TXMD con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TXMD	1.29	16.01M	996.00K	-6.09M	-9.76M	4.49
ZTS	176.42	79.51B	9.15B	2.43B	2.31B	4.92
TAK	13.53	42.89B	30.27B	1.93B	3.45B	0.444
HLN	9.43	42.57B	14.26B	1.55B	0	0.3327
TEVA	16.49	18.51B	16.77B	-959.00M	1.37B	-2.00
VTRS	13.00	15.37B	15.24B	-646.50M	1.88B	1.53

Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2020-08-07	Downgrade	Jefferies	Hold → Underperform
2020-05-19	Downgrade	JP Morgan	Overweight → Neutral
2019-12-02	Iniziato	Guggenheim	Buy
2019-10-17	Iniziato	H.C. Wainwright	Buy
2019-04-30	Ripresa	Noble Capital Markets	Outperform
2018-06-15	Iniziato	JP Morgan	Overweight
2017-09-08	Iniziato	Morgan Stanley	Equal-Weight
2017-07-11	Aggiornamento	Oppenheimer	Perform → Outperform
2017-05-09	Downgrade	Oppenheimer	Outperform → Perform
2016-11-22	Ripresa	Jefferies	Buy
2016-11-22	Iniziato	Oppenheimer	Outperform
2016-11-07	Ripresa	Guggenheim	Buy
2016-04-04	Iniziato	Goldman	Buy
2015-12-08	Reiterato	Jefferies	Buy
2015-12-08	Reiterato	Stifel	Buy
2015-09-21	Reiterato	Jefferies	Buy
2015-06-09	Iniziato	Guggenheim	Buy
2014-07-08	Iniziato	FBR Capital	Outperform
2014-04-17	Reiterato	Noble Financial	Buy
2014-01-28	Reiterato	Noble Financial	Buy

Mostra tutto

Therapeuticsmd Inc Borsa (TXMD) Ultime notizie

Nov 15, 2024

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

Nov 15, 2024

TXMD stock touches 52-week low at $1.43 amid market challenges - Investing.com

Nov 15, 2024

TherapeuticsMD Third Quarter 2024 Earnings: US$0.049 loss per share (vs US$0.13 loss in 3Q 2023) - Yahoo Finance

Nov 15, 2024

TherapeuticsMD, Inc. (NASDAQ:TXMD) Sees Large Increase in Short Interest - Defense World

Nov 15, 2024

Nov 14, 2024

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Nov 14, 2024

Nov 13, 2024

TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch

Nov 13, 2024

Nov 12, 2024

TherapeuticsMD Reports Reduced Losses Amid Strategic Shift - TipRanks

Nov 12, 2024

TherapeuticsMD: Q3 Earnings Snapshot - Houston Chronicle

Nov 12, 2024